Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.
about
Automated image analysis programs for the quantification of microvascular network characteristicsPhotoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition.Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers.Directional Histogram Ratio at Random Probes: A Local Thresholding Criterion for Capillary Images.Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.Enhancement of Gastric Ulcer Healing and Angiogenesis by Hepatocyte Growth Factor Gene Mediated by Attenuated Salmonella in Rats.Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity.The chicken chorioallantoic membrane model in biology, medicine and bioengineeringA key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies.Anticancer Organometallic Osmium(II)-p-cymene Complexes.Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.
P2860
Q27026176-EA566911-DF13-405E-92A9-FD148A59ACD7Q27329647-EF49235D-022F-410B-88C5-7854005F4F20Q30514153-8523635B-461C-43E7-9576-B8E216D44DFCQ36697169-EABCC3B1-0723-4298-885F-C73AEED8E852Q37294904-B88A9617-3C41-4496-AA99-76DED22FC0A5Q37295545-068D9146-D1E5-4D6D-8784-08540A238AF6Q37570120-E6E8ACD0-576F-429F-905E-9B513061D9CBQ37638911-BBA690FC-C70B-4D4B-ABA8-C5D2C417C8F1Q37657640-6BCD4494-A292-4797-AAAE-B28BE6F79A8CQ38241348-AD1786A1-2C86-40BE-9570-C07A7068B0BDQ38779512-58A9E63E-82E0-4350-B99F-749A2E8C711DQ38851401-85C436CA-0A69-45DA-9FFD-A79C56776ED7Q39178846-80136ECE-A3AD-42CA-9D21-CF06DBC50573Q41788258-2C723B1A-6A17-4FCC-BC47-3958A120EA16Q45158260-41067F89-BF83-4765-9386-E5F3D8A5B273
P2860
Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Processing of fluorescence ang ...... genic agents in the CAM model.
@ast
Processing of fluorescence ang ...... genic agents in the CAM model.
@en
Processing of fluorescence ang ...... genic agents in the CAM model.
@nl
type
label
Processing of fluorescence ang ...... genic agents in the CAM model.
@ast
Processing of fluorescence ang ...... genic agents in the CAM model.
@en
Processing of fluorescence ang ...... genic agents in the CAM model.
@nl
prefLabel
Processing of fluorescence ang ...... genic agents in the CAM model.
@ast
Processing of fluorescence ang ...... genic agents in the CAM model.
@en
Processing of fluorescence ang ...... genic agents in the CAM model.
@nl
P2093
P1476
Processing of fluorescence ang ...... ogenic agents in the CAM model
@en
P2093
Hubert van den Bergh
Jean-Pierre Ballini
Patrycja Nowak-Sliwinska
P356
10.1016/J.MVR.2009.10.004
P577
2009-10-24T00:00:00Z